Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Earnings
News

Cerevel Therapeutics Hldg Q3 EPS $(0.43) Misses $(0.40) Estimate

Cerevel Therapeutics Hldg (NASDAQ:CERE) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.40) by 7.5 percent.

byBenzinga Newsdesk

November 10, 2021

1 minute read

Cerevel Therapeutics Hldg (NASDAQ:CERE) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.40) by 7.5 percent.